The need for a parenteral treatment should be assessed and if considered necessary the  injectable proton pump inhibitors in the table may be considered to offer a suitable clinical alternative to intravenous ranitidine, in conjunction with the reader’s own professional knowledge and clinical judgement, the circumstances of the individual patient and all relevant pharmaceutical and healthcare literature and guidelines, or following and in conjunction with consultation with a qualified medical professional.